NCT06782204View on ClinicalTrials.gov

Variability of Sulfotransferase Activity in Humans: an Approach to Improve Predictive Drug Response Part II: Analysis of Interindividual Variation in Hypertensive Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

April 1, 2021

Conditions
Hypertension
Interventions
DRUG

Paracetamol

At visit 2, complying subjects will receive a tablet containing 1 gram of paracetamol and have blood and urine samples collected 2 hours after administration.

Trial Locations (1)

1500-650

Hospital da Luz, Lisbon

All Listed Sponsors
collaborator

Universidade Nova de Lisboa

OTHER

lead

Hospital da Luz, Portugal

OTHER

NCT06782204 - Variability of Sulfotransferase Activity in Humans: an Approach to Improve Predictive Drug Response Part II: Analysis of Interindividual Variation in Hypertensive Patients | Biotech Hunter | Biotech Hunter